← FDA Drug Approvals (Drugs@FDA)

OSELTAMIVIR PHOSPHATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACCORD HLTHCARE · Approved 2022-07-25

Drug application

FDA Application #

ANDA214726

Application type

Abbreviated New Drug Application (Generic)

Brand name

OSELTAMIVIR PHOSPHATE

Generic name

Oseltamivir Phosphate

Active ingredients

OSELTAMIVIR PHOSPHATE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Discontinued

Sponsor

ACCORD HLTHCARE

First approval

2022-07-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown